Weblog met nieuws over de pharmaceutische industrie
5 May
After last week’s flurry of FDA warning letters directed at companies marketing through
search ads, industry is left wondering what can be done be done to target patients online?
Lees meer..
20 Mar
Pharm Exec sits down with Kathryn Metcalfe, Pfizer’s new vice president of corporate reputation and
policy communications to discuss the new position, the perception of pharma among laypeople, and what needs to be
done to boost public opinion of the drug industry.
Lees meer..
20 Mar
With the economy in turmoil, pharmaceutical manufacturers are reassessing where and how they spend
their advertising dollars.
Lees meer..
6 Mar
Manhattan Research singled out type 2 diabetes sufferers and their online search patterns; it turns
out diabetes patients are less likely to confront doctors about branded drugs they?ve seen in DTC ads, yet more apt
to take Lipitor.
Lees meer..
6 Mar
GlaxoSmithKline received a warning letter for use of misleading imagery in its television ad for
Avodart. The Feds felt that comparing prostate size to planets might not be a good idea.
Lees meer..
4 Mar
To stay on top of a constantly evolving market that presents new challenges every day, product
managers need to bolster branding strategies and raise their marketing IQ.
Lees meer..
4 Mar
Companies are tightening their purse strings just when brand strategies need to target new
audiences
Lees meer..
19 Feb
Two pharma companies dabble in online video in two different but effective ways. Sanofi-aventis
attempts to reach patients through educational videos, while AZ calls for consumers to upload their own
testimonials.
Lees meer..
5 Feb
Pfizer switched agencies for its popular smoking cessation drug Chantix. While the company is tight
lipped about the campaign’s new direction, it looks like this may be the end of the tortoise and hare. Does this
signal an end to the use of critters in pharma ads?
Lees meer..
25 Jan
A new study suggests the medical professionals are more active on social networking sites than ever
before. With the rise of doctor-specific Web 2.0 outlets, pharma has a new tool for reaching elusive physicians.
The best part: Doctors don?t seem to mind.
Lees meer..